A Functional Exercise Program Improves Pain and Health Related Quality of Life in Patients With Fibromyalgia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03682588 |
|
Recruitment Status : Unknown
Verified September 2018 by Giovana Fernandes, Federal University of São Paulo.
Recruitment status was: Recruiting
First Posted : September 24, 2018
Last Update Posted : September 28, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Fibromyalgia | Other: Physical activity | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 68 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Randomized controlled trial |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | Randomised electronically generated randomisation table. Secret allocation (sealed opaque envelopes). |
| Primary Purpose: | Treatment |
| Official Title: | A Functional Exercise Program Improves Pain and Health Related Quality of Life in Patients With Fibromyalgia: A Randomized Controlled Trial |
| Actual Study Start Date : | July 1, 2017 |
| Actual Primary Completion Date : | July 1, 2018 |
| Estimated Study Completion Date : | August 1, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Functional exercise group
Functional exercise program with 14 exercises, two times/week, during 14 weeks. Two sets of 10 repetitions each, with 30 seconds interval.
|
Other: Physical activity
The Functional exercise group performed functional exercise training for 45 minutes twice a week for 14 weeks. The Stretching exercise group performed stretching exercises with the same duration and frequency.
Other Name: Functional exercise group and Stretching exercise group |
|
Active Comparator: Stretching exercise group
Stretching exercise program with 17 exercises, two times/week, during 14 weeks and each movement was repeated by three times and held for 20 seconds each
|
Other: Physical activity
The Functional exercise group performed functional exercise training for 45 minutes twice a week for 14 weeks. The Stretching exercise group performed stretching exercises with the same duration and frequency.
Other Name: Functional exercise group and Stretching exercise group |
- Change in pain [ Time Frame: Baseline, after 7, 14, 26 and 38 weeks ]Evaluated using the Visual Analogue Scale for pain. Scores ranges from 0 to 10 with higher values represent a worse pain.
- Change in Muscular Strength [ Time Frame: Baseline, after 7, 14, 26 and 38 weeks ]Evaluated using the one-repetition maximum test
- Change in functional performance [ Time Frame: Baseline, after 7, 14, 26 and 38 weeks ]Evaluated using the Time-up and go test
- Change in balance [ Time Frame: Baseline, after 7, 14, 26 and 38 weeks ]Evaluated using the Berg balance scale to evaluate balance. Scores ranges from 0 to 56 with higher values represent a worse balance.
- Change in Flexibility [ Time Frame: Baseline, after 7, 14, 26 and 38 weeks ]Evaluated using the sit and reach test (Wells Bench)
- Change in General quality of life [ Time Frame: Baseline, after 7, 14, 26 and 38 weeks ]Evaluated using the Short-form 36 questionnaire for quality of life. Scores ranges from 0 to 100 with higher values represent a better quality of life..
- Change in medications consumption [ Time Frame: Baseline, after 7, 14, 26 and 38 weeks ]Evaluated the amount of acetominophen (500mg de 6/6 hours) used for pain
- Change in health-related quality of life [ Time Frame: Baseline, after 7, 14, 26 and 38 weeks ]Evaluated using the Fibromyalgia Impact Questionnaire. Scores ranges from 0 to 100 with higher values represent a worse quality of life..
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Female sex
- Classification of fibromyalgia based on the criteria of the American College of Rheumatology
- Age 18 to 65 years;
- Pain intensity between 4 and 8cm on a visual analog scale ranging from 0 to 10cm
- Stable medication for at least three months
Exclusion Criteria:
- Uncontrolled cardiorespiratory disease
- Health condition for which physical exercise was contraindicated
- Serious psychiatric disorder
- Uncontrolled diabetes mellitus
- Inflammatory rheumatic disease
- History of regular physical exercise (30min, 3 times a week) in the previous 3 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03682588
| Contact: Giovana Fernandes | +55 11 981341963 | giovanafernandes.cp@gmail.com | |
| Contact: Rheumatology Division Rheumatology Division | +55 11 5539-0893 |
| Brazil | |
| Rheumatology outpatient clinics of a university hospital; | Recruiting |
| São Paulo, SP, Brazil, CEP 04039-002 | |
| Contact: Giovana Fernandes giovanafernandes.cp@gmail.com | |
| Study Director: | Jamil Natour, Professor | Federal University of São Paulo |
| Responsible Party: | Giovana Fernandes, PhD Student, Federal University of São Paulo |
| ClinicalTrials.gov Identifier: | NCT03682588 |
| Other Study ID Numbers: |
719.779 |
| First Posted: | September 24, 2018 Key Record Dates |
| Last Update Posted: | September 28, 2018 |
| Last Verified: | September 2018 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Fibromyalgia Treatment Exercise |
|
Fibromyalgia Myofascial Pain Syndromes Muscular Diseases Musculoskeletal Diseases |
Rheumatic Diseases Neuromuscular Diseases Nervous System Diseases |

